EAM
KYNB

Eagle Asset Management’s Kyntra Bio KYNB Stock Holding History

Eagle Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33,132
Closed -$15.5M – 549
2023
Q1 		$15.5M Sell
33,132
-2,993
-8% -$1.58M 0.09% 192
2022
Q4 		$14.4M Buy
36,125
+6,580
+22% +$2.52M 0.09% 197
2022
Q3 		$9.61M Buy
+29,545
New +$9.52M 0.06% 245
2019
Q2 		– Sell
-37,888
Closed -$51.5M – 648
2019
Q1 		$51.5M Buy
37,888
+101
+0.3% +$137K 0.27% 145
2018
Q4 		$43.7M Sell
37,787
-687
-2% -$772K 0.28% 149
2018
Q3 		$58.4M Sell
38,474
-394
-1% -$607K 0.28% 146
2018
Q2 		$60.8M Buy
38,868
+6,063
+18% +$7.9M 0.33% 115
2018
Q1 		$37.9M Buy
32,805
+50
+0.2% +$65.8K 0.21% 174
2017
Q4 		$39M Sell
32,755
-423
-1% -$530K 0.21% 168
2017
Q3 		$46.2M Buy
+33,178
New +$35M 0.26% 136

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Asset Management's KYNB Position: Q2 2023 in Review

Eagle Asset Management sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 33,132 shares — an estimated $15.5M sold.

Eagle Asset Management first reported a position in KYNB in Q3 2017 and held it in 10 quarters. The position peaked at $60.8M in Q2 2018. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Eagle Asset Management reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Eagle Asset Management sold 33,132 Kyntra Bio shares in Q2 2023, an estimated $15.5M.
  • Eagle Asset Management first reported a position in Kyntra Bio in Q3 2017 and held it in 10 quarters.
  • Eagle Asset Management's Kyntra Bio position peaked at $60.8M in Q2 2018.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Eagle Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.